Chembond Material Technologies Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
CHEMBOND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.0 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Chembond Material Technologies Limited reported consolidated revenue of Rs. 25,007.40 lakhs for FY 2025-26, up 24.2% from Rs. 20,129.99 lakhs in FY 2024-25. However, profit after tax declined 26.6% to Rs. 1,289.07 lakhs from Rs. 1,756.24 lakhs in the previous year. EBITDA margin contracted from approximately 10.1% to 8.2% year-on-year due to rising raw material costs and other expenses. The company recommended a dividend of Rs. 2 per equity share (40% on face value of Rs. 5). Auditors M/s. Kastury & Talati issued unmodified opinions on both standalone and consolidated financial statements. Standalone PAT declined more sharply from Rs. 1,722.36 lakhs to Rs. 775.88 lakhs. The company operates in two segments: Specialty Chemicals and Animal Health.
The stock may face pressure due to significant PAT decline and margin compression despite revenue growth. The 24% revenue growth is positive but profit decline suggests cost pressures. The dividend recommendation provides some shareholder returns. Investors should monitor raw material cost trends in FY27.